Indiana Lawmakers Approve Bill To Ban Marijuana Advertising On Billboards

Tuesday discussion around a Bureau of Motor Vehicle (BMV) bill descended into impassioned debate over marijuana advertising, which Republican lawmakers said should be restricted.

In contention was House Bill 1390, authored by Rep. Jim Pressel (R-Rolling Prairie). The underlying legislation originally just dealt with BMV agency matters, like insurance verification, specialty license plates and registration stickers.

But among multiple changes adopted by the Senate Homeland Security and Transportation Committee on Tuesday—including a significant amendment addressing “predatory” towing—was a ban on “outdoor” marijuana advertising, notably on highway billboards.

Specifically, the amended bill language seeks to prohibit outdoor advertisements for products containing marijuana or a variety of other controlled substances, including heroin, LSD and ecstasy.

The bill now moves to the Senate Appropriations Committee.

Pressel, whose district extends to Indiana’s northern border, described “billboards all over the place that say, ‘Come to my store and buy this,’” referencing dispensaries in Michigan, where recreational marijuana is legal.

“And we have trucks—mobile billboards—that drive around and sit in front of our parks. That’s unacceptable, and it sends a mixed message to the consumer that this product is legal in Indiana, which it is not,” said Pressel, who unsuccessfully attempted to add the provision to a separate House bill earlier in the session.

“I think that’s an unfair message,” he continued, “and I believe that we should get in front of this to say that if it’s an illegal substance, listed on our illegal substance list in the state of Indiana, you should not be able to advertise for that.”

Multiple advertisers pushed back.

Ron Breymier, executive director of the Outdoor Advertising Association of Indiana, cited First Amendment issues. He argued that policymakers can dictate the size and placement of billboards, but “not the actual advertisement itself.”

Phones and internet searches, Breymier said, are a “greater threat” than billboards.

Keep reading

DEA Promotes ‘Anti-420 Day’ Contest For Young People To ‘Flood’ Instagram With Marijuana Warnings

The Drug Enforcement Administration (DEA) is promoting an “Anti-420 Day” campaign that’s recruiting students to send short videos warning their peers about marijuana use.

In a bulletin that was distributed on Tuesday, DEA’s JustThinkTwice.com site shared details about the campaign, which is being run by the anti-cannabis nonprofit organization Johnny’s Ambassadors.

“Be an Instagram Influencer for Anti-420 Day,” the message says. “Johnny’s Ambassadors is hiring teens and young adults (high school and college students) to create original videos about the harms of youth THC use for Anti-420 Day.”

The plan is to “flood” Instagram with the short-form videos that would feature students talking about “why young people should not use THC.”

Students would be eligible for a $25 Amazon gift card for a personal video, $35 for a group video and $50 for a “professionally produced educational video or skit with adult sponsor supervision.”

“Your video should either be an educational Youth THC Prevention video on why young people shouldn’t use THC products (vapes, dabs, weed, edibles, gummies) OR a personal story of how you have been impacted by THC use (yourself, a friend, a family member, or a loved one),” the organization said.

It also provided examples of potential prompts, including explainers on “why THC impacts athletic performance on a team” and busting “commonly-held but incorrect myth about THC.”

“Tell a personal story about how you’ve been negatively impacted by THC use” or perform a “skit or drama to educate other teens why using products with THC is bad for you,” the description from Johnny’s Ambassadors—which was founded the parents of a child who died by suicide after consuming high potency marijuana concentrates—says.

There are some restrictions on the content, including a ban on “swearing” in the videos. And no content is allowed that “depicts, imitates, or promotes the possession or consumption of any THC product.”

“DO NOT IMITATE THE USE OF THC/MARIJUANA OR PARAPHERNALIA OF ANY KIND, EVEN AS A JOKE,” it emphasizes.

Keep reading

Bungling police raid ‘terrified’ elderly couple’s home in search for cannabis farm after thermal camera mistook the heating in terraced home for drugs den

An elderly couple who like to keep the heating on at home were left ‘shaking in fear’ when police burst into their home searching for a cannabis farm – after a thermal camera on a helicopter wrongly identified it as a drugs den.

Pensioners Barry and Mavis Lovelock were finishing their breakfast when the ‘terrifying’ raid took place.

Nine officers stormed in because a helicopter camera had mistakenly identified their toasty terrace home as a potential cannabis grow.

But after charging upstairs looking for cannabis plants and the strong lamps used to grow them, the sheepish officers came back down empty-handed after quickly concluding their tip-off had been ‘not fully accurate’. 

The heat signature on the couple’s roof had instead been caused by their two gas fires, which they keep on around-the-clock in the colder months.

Leicestershire Police has now apologised. They said another raid on a separate property in the street in Newfoundpool, Leicester, had found a large cannabis farm, with 79 plants being seized.

Mrs Lovelock said the ‘awful’ incident, which took place on March 15 at the property the couple had lived in since 1978, had left her in tears.

She said: ‘They told us the camera on the helicopter had noticed our roof glowing white but that was just because we have the heating on all of the time.

‘People of our age feel the cold so we need the heating on. 

‘We have two new gas fires downstairs and the gas engineer told us they will warm the whole house and they do. We keep the doors open and the heat circulates. We have electric wall heaters too, but we only need to put the electric heater on in the back bedroom.’

She said the couple had just finished their breakfast when she noticed a group of police officers outside as her husband, a retired water board worker, went to make another cup of tea.

Mrs Lovelock said that police then ‘hit the door’, prompting Mr Lovelock to shout: ‘Hang on mate’, before somebody shouted ‘Stand clear’ from the street outside.

She added: ‘They just rammed the door in. It was awful. They knocked the gate at the back in as well.

‘It was terrifying and I said to them, ‘What the devil do you think you’re doing? There’s two pensioners here.’

The couple, who celebrated their Golden Wedding anniversary last year, were shown a warrant with their house number on it.

Mrs Lovelock, a former hospital worker, added: ‘They got in and two of them ran upstairs, but they only went to the top of the stairs and ran back down.

‘I think there were about nine of them altogether, maybe more.

Keep reading

UN Drug Commission Votes To Ban Previously Uncontrolled Marijuana Compound, With U.S. Abstaining

The United Nations (UN) Commission on Narcotic Drugs (CND) voted this week to ban the marijuana component hexahydrocannabinol (HHC) under an international treaty, with every country present except the United States casting a vote in favor of placing the substance under Schedule II of the 1971 Convention on Psychotropic Substances.

The U.S., for its part, abstained. In a statement afterward, officials said they were “unable to vote” on the HHC proposal as well as another being voted on that placed the drug carisoprodol under Schedule IV.

“While the United States supports the use of the international scheduling system to make scientifically-informed decisions about international drug control, we were unable to vote on the proposals,” the statement said. “Nevertheless, both of these substances are already controlled in the United States, at levels that will allow the United States to meet its international obligations arising from the CND’s decisions today.”

The statement gave no further information explaining why the U.S. was unable to cast those votes.

CND also voted to regulate four other non-cannabis compounds under international law.

In a social media post, the UN Office on Drugs and Crime (UNODC) called the actions “critical decisions on the control of harmful substances.”

“These decisions shape drug policies, law enforcement and public health worldwide,” the body said.

Keep reading

Federal Memo From National Cancer Institute Lists Marijuana As ‘Controversial ‘Topic That Needs Special Approval Before Publication

“Marijuana” is one of nearly two dozen “controversial or high-profile topics” that staff and researchers at the National Cancer Institute (NCI) are required to clear with higher-ups before writing about, according to a newly leaked memo from within the federal agency.

The government directive puts marijuana and opioids on a list along with vaccines, COVID-19, fluoride, measles, abortion, autism, diversity and gender ideology and other issues that are believed to be personal priorities of Health and Human Services Secretary Robert F. Kennedy Jr. and President Donald Trump.

NCI is part of the National Institutes of Health (NIH), which itself is part of the Department of Health and Human Services (HHS).

Prior to publishing anything on the specified topics, NCI staff are required to send the materials to an agency clearance team, says the new memo, first reported by ProPublica.

“Depending on the nature of the information, additional review and clearance by the NCI director, deputy directors, NIH, and HHS may be required,” it advises staff. “In some cases, the material will not need further review, but the NCI Clearance Team will share it with NCI leadership, NIH, and/or HHS for their awareness.”

It notes that staff “do not need to share content describing the routine conduct of science if it will not get major media attention, is not controversial or sensitive, and does not touch on an administration priority,” according to the ProPublica report.

The investigative news outlet says the directive “was circulated by the institute’s communications team, and the content was not discussed at the leadership level,” adding that “it is not clear in which exact office the directive originated.”

Experts said the policy could have a chilling effect, slowing publication of important findings and pushing researchers to censor their work.

Keep reading

Coating Dentures With CBD Can Help Prevent Oral Infections, Government-Funded Study Shows

A newly published journal article says the cannabis component CBD could be an effective way to avoid oral infections when incorporated into the primary material used in dentures.

Published last month in the journal Molecules, the government-funded research says bonding CBD to dentures demonstrates “potential for antibiotic-free denture coatings, reducing dental biofilms and plaque formation, and improving oral health outcomes.”

To study the properties of CBD in dentures, researchers incorporated the cannabinoid into a type of plastic known as poly(methyl methacrylate) (PMMA), which the paper explains is “the primary material for dentures due to its favorable physical and aesthetic qualities.” Researchers then tested antimicrobial activity against three types of bacteria: Staphylococcus aureusEscherichia coli and Streptococcus agalactiae.

Results showed that the CBD denture coatings had “significant bactericidal effects” against so-called Gram-positive bacteria. In terms of Gram-negative bacteria—which are typically more resistant to antibiotics—the CBD coating was ineffective against free-floating, so-called “planktonic” Gram-negative bacteria but effectively eliminated communities of bacteria known as biofilms.

“Biofilm studies revealed a 99% reduction in biofilm growth for both Gram-positive and Gram-negative bacteria on CBD-infused PMMA compared to standard PMMA,” the report says. “The CBD disrupted bacterial cell ways, causing lysis,” or the breakdown of the cell itself.

“In summary,” authors wrote, “biofilm studies showed PMMA/CBD coatings were effective in eradicating all the pathogens on their surface.”

Keep reading

Using Marijuana Every Day Could Help People Quit Opioids, New Study Indicates

A newly published study found that among drug users who experience chronic pain, daily cannabis use was linked to a higher likelihood of quitting the use of opioids—especially among men.

“Participants reporting daily cannabis use exhibited higher rates of cessation compared to less frequent users or non-users,” says the report, published last week in the journal Drug and Alcohol Review.

When results were split by sex, researchers observed that “daily cannabis use was significantly associated with increased rates of opioid cessation among males.” Those differences “suggest potential differences in cannabis use behavior and effects,” the paper says, and underscores the need for further research.

The report was authored by an eight-person research team from the British Columbia Centre on Substance Abuse as well as the University of British Columbia and Simon Fraser University.

Between June 2014 and May 2022, the team examined data from 1,242 people who used drugs (PWUD) while also living with chronic pain. Of those, 764 experienced “a cessation event.”

Daily cannabis use, it says, “was positively associated with opioid cessation.”

“Our findings add to the growing evidence supporting the potential benefits of cannabis use among PWUD, underlining the need for further research,” authors wrote.

Indeed, a growing body of research to date has examined the associations between cannabis reform and opioids, often finding reductions in opioid use in areas that legalize marijuana for medical or adult use.

A recent federally funded study in the U.S., for example, found an association between state-level marijuana legalization and reduced prescriptions for opioid pain medications among commercially insured adults—indicating a possible substitution effect where patients are choosing to use cannabis instead of prescription drugs to treat pain.

That research, which was supported by a grant from the National Institute on Drug Abuse, looked at national records of opioid prescription fills as well as prescribing of non-steroidal anti-inflammatory drugs (NSAIDs) and other pain medications. Analysis showed that prescription opioid fills dropped following legalization in U.S. while prescribing of non-opioid pain medications saw “marginally significant increases.”

Keep reading

California State Fair Will Again Feature On-Site Marijuana Sales And Consumption, With New Award Categories For Blunts, Hash And Chocolates

The California State Fair will once again feature a cannabis exhibit and competition at this year’s event, with expanded award categories meant to showcase the diversity of the state’s market.

This is the fourth year that California’s annual event has invited marijuana entrepreneurs and consumers to join the festivities—and, for the second year in a row, on-site sales and consumption will be permitted during the 17-day fair.

“Last year, we made history by integrating cannabis sales and consumption into the State Fair, and we are thrilled to return in 2025,” Lauren Carpenter, co-founder of Embarc, which is facilitating the sales component, said. “Through an immersive educational experience, we’re shining a light on the cannabis brands reflecting and shaping cannabis culture in California and beyond.”

As for the competition, there are 150 medals available this year. Submissions will open on March 1 and close on May 4. The winners will be announced at the start of the fair on July 11.

This year’s award categories have been expanded to include cannabis blunts, hash and chocolates.

“For more than 170 years the California State Fair has had a long-standing tradition of celebrating the best of the Golden State, especially those who epitomize the state’s agricultural excellence,” Tom Martinez, CEO of the California State Fair, said. “Since welcoming cannabis to the Fair, we’ve witnessed firsthand the pride and dedication of California’s cannabis cultivators, who are crafting some of the best products, not just in the state, but in the entire industry.”

Other categories up for awards include indoor, outdoor and mixed-light flower, beverages, cartridges, concentrates, edibles, pre-rolls and wellness.

Keep reading

Idaho Governor Signs Bill Setting Mandatory Minimum Fine For Marijuana Possession

Idaho’s governor has signed a bill creating a new mandatory minimum fine for possession of marijuana.

Under the legislation approved by Gov. Brad Little (R) on Monday, adults caught with less than three ounces of cannabis will face a mandatory minimum fine of $300.

Sponsor Rep. Bruce Skaug (R), the sponsor of the measure, told a House committee last month that “we do not want this to become a marijuana state.”

On the House floor, the representative asked colleagues: “Tell me what state—anybody who debates against this bill—what state is a better place because of the passage of marijuana legalization? I submit none.”

He later told a Senate committee that “a $300 fine is not too much if you can afford to buy this marijuana and concentrate.”

“Every dollar spent on pot by someone is not spent on food, clothing, school supplies, real medicine or housing,” he said.

The new law is set to take effect on July 1.

Keep reading

Using The Marijuana Components THC-V And CBD Every Day Helps People Lose Weight, Study Finds

Research on the use of marijuana components to aid weight loss found that use of a combined product containing the cannabinoids THCV and CBD “was associated with statistically significant weight loss” as well as a slimmer waistline, lower blood pressure and decreased cholesterol.

The study, published late last month in the journal Cannabis, analyzed outcomes among 44 people who were administered either oral strips containing a mixture of the two cannabinoids or a placebo. Participants took one strip daily for 90 says and were evaluated for weight loss and certain metabolic markers.

“Use of the THCV/CBD strip was associated with statistically significant weight loss, decreases in abdominal girth, systolic blood pressure, and total and LDL cholesterol,” says the report, authored by Dr. Gregory Smith, the founder and CEO of plant-based medicine company NeX Therapeutics, based in Florida.

Participants—31 of whom were female and 13 of whom were male, with a combined average age of about 52 years—were given either a placebo or one of two different mucoadhesive oral strips. A lower-dose version contained 8 milligrams of THCV and 10 mg CBD, while a higher-dose version had 16 mg THCV and 20 mg CBD. Subjects received a reminder to take a dose each day on an empty stomach and report any side effects, and they agreed to refrain from using cannabis or other cannabinoid-based products.

Participants were not asked to make any changes to their diet or exercise routines.

Of 24 people who received the lower-potency oral strips, 16 (66.7 percent) demonstrated weight loss over the course of the 90-day period—on average losing 2.6 kilograms (5.7 pounds). Among the 10 who received the higher-dose strips, seven (70 percent) lost weight—an average of 4.1 kg (9.0 lbs).

The 10 subjects who received the placebo, meanwhile, lost an average of just 0.1 kg (0.2 lbs).

Nearly all (95.8 percent) in the lower-dose group also saw reductions in abdominal girth, as did 70 percent of the higher-dose subjects.

“It is interesting to note that there was a barely statistically significant decrease in the control/placebo group,” Smith wrote, “however, it is also worth noting that abdominal girth is probably the least accurate of all the biometric measures taken for the purposes of this study.”

The THCV/CBD groups also showed reductions in systolic blood pressure as well as total and LDL cholesterol, the research found.

“In summary, 90 day use of once-daily THCV and CBD-infused mucoadhesive strips was associated with clinically significant weight loss, decreases in abdominal girth, systolic blood pressure, and total and LDL cholesterol,” the report concludes, adding that stronger dosage appeared to perform better: “The 16mg/20mg daily dose in Group B was superior for weight loss compared to the 8mg/10mg daily dose in Group A.”

Keep reading